These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9489089)

  • 41. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
    Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Risks and benefits of postmenopausal hormone replacement therapy].
    Szántó F
    Orv Hetil; 1998 Nov; 139(44):2639-42. PubMed ID: 9842237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HRT and women who have had breast or endometrial cancer.
    Creasman WT
    J Epidemiol Biostat; 1999; 4(3):217-20; discussion 221-5. PubMed ID: 10695960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
    Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
    Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Menopause and hormone replacement therapy].
    Tóth KS
    Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Educating patients about the benefits and drawbacks of hormone replacement therapy.
    Rozenberg S; Vasquez JB; Vandromme J; Kroll M
    Drugs Aging; 1998 Jul; 13(1):33-41. PubMed ID: 9679207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selecting patients for HRT: positive indications.
    Ross D; Whitehead MI
    Br J Clin Pract; 1995; 49(2):92-4. PubMed ID: 7779652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormone replacement therapy and diabetes mellitus.
    Dunne FP; Harris P; Keane L; Jenkins D; Wright AD
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):615-20. PubMed ID: 8759173
    [No Abstract]   [Full Text] [Related]  

  • 51. Hormone replacement therapy in postmenopausal women with diabetes mellitus: a risk-benefit assessment.
    Andersson B
    Drugs Aging; 2000 Nov; 17(5):399-410. PubMed ID: 11190419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hormone replacement therapy and breast cancer, endometrial cancer and cardiovascular disease: risks and benefits.
    Goddard MK
    Br J Gen Pract; 1992 Mar; 42(356):120-5. PubMed ID: 1493029
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HRT and cancer risk: separating fact from fiction.
    Schneider HP
    Maturitas; 1999 Nov; 33 Suppl 1():S65-72. PubMed ID: 10661617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Should estrogen replacement therapy be applied in women with genital and breast cancer?].
    Bösze P
    Orv Hetil; 1995 Feb; 136(8 Suppl 1):465-72. PubMed ID: 7877821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Risk and benefit assessment in hormone replacement therapy].
    Ohta H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():301-5. PubMed ID: 18161122
    [No Abstract]   [Full Text] [Related]  

  • 56. The benefits of oestrogen following menopause: why hormone replacement therapy should be offered to postmenopausal women.
    Wren BG
    Med J Aust; 2009 Mar; 190(6):321-5. PubMed ID: 19296814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perimenopausal and postmenopausal hormone replacement therapy: Part 1. An update of the literature on benefits and risks.
    Solomon D
    J Nurse Midwifery; 1996; 41(3):228-9. PubMed ID: 8708809
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hormone replacement treatment and cardiovascular disease].
    Iglesias Rodal M; Espinosa González N; Berdier Soriano R; Marzo Castillejos M
    Aten Primaria; 1999 Mar; 23(5):313-4. PubMed ID: 10341467
    [No Abstract]   [Full Text] [Related]  

  • 59. Differences in providers' beliefs about benefits and risks of hormone replacement therapy in managed care.
    Exline JL; Siegler IC; Bastian LA
    J Womens Health; 1998 Sep; 7(7):879-84. PubMed ID: 9785314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Postmenopausal estrogen replacement therapy--does it reduce morbidity and mortality from ischemic heart disease?].
    Zyssman I; Schlezinger Z
    Harefuah; 1996 Feb; 130(3):200-3. PubMed ID: 8682400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.